O'Shaughnessy Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,336	Closed	-$290K	–	1689
2023 Q2	$290K	Sell	1,336 -31	-2%	-$6.64K	﹤0.01%	1068
2023 Q1	$248K	Sell	1,367 -102	-7%	-$19.5K	﹤0.01%	1124
2022 Q4	$289K	Sell	1,469 -8	-0.5%	-$1.72K	﹤0.01%	986
2022 Q3	$332K	Buy	+1,477	New	+$299K	0.01%	895
2021 Q4	–	Sell	-546	Closed	-$67K	–	2635
2021 Q3	$67K	Hold	546	–	–	﹤0.01%	1539
2021 Q2	$62K	Buy	+546	New	+$63.8K	﹤0.01%	1502

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

O'Shaughnessy Asset Management's KRTX Position: Q3 2023 in Review

O'Shaughnessy Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2023, closing a stake of 1,336 shares — an estimated $290K sold.

O'Shaughnessy Asset Management first reported a position in KRTX in Q2 2021 and held it in 6 quarters. The position peaked at $332K in Q3 2022. 256 funds tracked by Wall St. Rank hold KRTX as of Q3 2023.

O'Shaughnessy Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
O'Shaughnessy Asset Management sold 1,336 Karuna Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $290K.
O'Shaughnessy Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
O'Shaughnessy Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $332K in Q3 2022.
256 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2023.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.